Valeurs

Le rangement donne un aperçu de toutes les valeurs mobilières classées de manière alphabétique ou selon les indices.

Show advanced options
 Abpro Holdings ABP 24. avr 2025 0.33 +2.10   
 Abrdn Global Dynamic Dividend Fund AGD 24. avr 2025 9.76 +1.67   
 Abrdn Global Premier Properties Fund AWP 24. avr 2025 3.79 +1.34   
 Abrdn Healthcare Opportunities Fund Shares Of Beneficial Int THQ 24. avr 2025 18.93 +1.12   
 Abrdn Life Sciences Investors Shares Of Beneficial Interest HQL 24. avr 2025 12.61 +2.35   
 Abrdn National Municipal Income Fund VFL 24. avr 2025 9.73 +1.73   
 Abrdn Total Dynamic Dividend Fund AOD 24. avr 2025 8.13 +1.50   
 Abrdn World Healthcare Fund Shares Of Beneficial Interest THW 24. avr 2025 10.62 +0.95   
 Absci ABSI 24. avr 2025 3.22 +0.94   
 ABVC Biopharma ABVC 24. avr 2025 0.91 +4.00   
 Ac Immune SA ACIU 24. avr 2025 1.66 +5.06   
 Acacia Research ACTG 24. avr 2025 3.07 +3.02   
 Academy Sports and Outdoors ASO 24. avr 2025 38.05 +1.17   
 Acadia Healthcare ACHC 24. avr 2025 22.18 +4.62   
 Acadia Pharmaceuticals ACAD 24. avr 2025 14.83 +1.44   
 Acadia Realty Trust AKR 24. avr 2025 19.60 -0.96   
 Acadian Asset Management AAMI 24. avr 2025 26.96 +1.81   
 Accel Entertainment ACEL 24. avr 2025 11.25 +0.72   
 Accelerate Diagnostics AXDX 24. avr 2025 0.54 -2.92   
 Accenture A ACN 24. avr 2025 291.41 +1.13   
 ACCESS Newswire ACCS 24. avr 2025 8.57 0.00   
 Acco Brands ACCO 24. avr 2025 3.88 +3.19   
 Accolade ACCD 24. avr 2025 7.02 0.00   
 Accuray ARAY 24. avr 2025 1.54 +0.65   
 Acelyrin SLRN 24. avr 2025 2.17 -3.56   
 Achieve Life Sciences ACHV 24. avr 2025 2.40 -1.23   
 ACI Worldwide ACIW 24. avr 2025 52.03 +0.74   
 Aclarion ACON 24. avr 2025 7.64 -0.78   
 Aclaris Therapeutics ACRS 24. avr 2025 1.27 +6.72   
 ACM Research A ACMR 24. avr 2025 20.88 +5.83   
 


Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer. The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.


Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer. The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.

Titlex

OK
+

Cookie consent

We use cookies to give you a better user experience. If you continue to use the website, you accept this. For further details click here.